1. Home
  2. CDT vs BON Comparison

CDT vs BON Comparison

Compare CDT & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • BON
  • Stock Information
  • Founded
  • CDT 2019
  • BON 2006
  • Country
  • CDT United States
  • BON China
  • Employees
  • CDT N/A
  • BON N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • BON Medicinal Chemicals and Botanical Products
  • Sector
  • CDT Health Care
  • BON Health Care
  • Exchange
  • CDT Nasdaq
  • BON Nasdaq
  • Market Cap
  • CDT 11.9M
  • BON 9.9M
  • IPO Year
  • CDT N/A
  • BON 2021
  • Fundamental
  • Price
  • CDT $0.11
  • BON $1.45
  • Analyst Decision
  • CDT
  • BON
  • Analyst Count
  • CDT 0
  • BON 0
  • Target Price
  • CDT N/A
  • BON N/A
  • AVG Volume (30 Days)
  • CDT 24.0M
  • BON 16.8K
  • Earning Date
  • CDT 11-18-2024
  • BON 10-29-2024
  • Dividend Yield
  • CDT N/A
  • BON N/A
  • EPS Growth
  • CDT N/A
  • BON N/A
  • EPS
  • CDT N/A
  • BON 2.19
  • Revenue
  • CDT N/A
  • BON $25,555,939.00
  • Revenue This Year
  • CDT N/A
  • BON $47.04
  • Revenue Next Year
  • CDT N/A
  • BON $77.63
  • P/E Ratio
  • CDT N/A
  • BON $0.68
  • Revenue Growth
  • CDT N/A
  • BON N/A
  • 52 Week Low
  • CDT $0.10
  • BON $1.23
  • 52 Week High
  • CDT $7.83
  • BON $6.99
  • Technical
  • Relative Strength Index (RSI)
  • CDT 41.52
  • BON 38.35
  • Support Level
  • CDT $0.10
  • BON $1.40
  • Resistance Level
  • CDT $0.14
  • BON $1.68
  • Average True Range (ATR)
  • CDT 0.01
  • BON 0.13
  • MACD
  • CDT 0.00
  • BON -0.02
  • Stochastic Oscillator
  • CDT 18.06
  • BON 9.42

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas.

Share on Social Networks: